Prolidase [EC 3.4. 13.9] plays an important role in the recycling of prolin
e for collagen synthesis and cell growth. The increase in the enzyme activi
ty is correlated with the increased intensity of collagen turnover, thus re
flecting the intensity of collagen metabolism. Since estrogens alter collag
en metabolism, it can be assumed that the changes may be reflected by proli
dase activity. The effects of estrogen and antiestrogen (tamoxifen on the p
rolidase and collagenase activities and collagen biosynthesis) were measure
d in the estrogen-receptor (ER)-positive breast cancer cell line. Estradiol
stimulated collagen biosynthesis and extracellular prolidase and collagena
se activities in cultured MCF-7 cells without an effect on collagen accumul
ation in the extracellular matrix produced by these cells. On the other han
d, tamoxifen inhibited the estrogen-dependent stimulatory effect on collage
n biosynthesis but did not inhibit the stimulatory effect of estrogen on pr
olidase and collagenase activities. The inhibitory effect of tamoxifen on e
strogen-dependent stimulation of collagen synthesis in MCF-7 cells and lack
of its effect on estrogen-dependent stimulation of prolidase and collagena
se activities suggest that both processes (collagen synthesis and degradati
on) are independently regulated in MCF-7 cells, possibly through antagonist
, agonist and other estrogen receptor-independent actions of tamoxifen. Inc
reased extracellular prolidase activity in estrogen-stimulated MCF-7 cells
indicates potential diagnostic value of tissue prolidase in determining the
ER status of breast cancer.